You have 9 free searches left this month | for more free features.

Immune Thrombocytopenic Purpura (ITP)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Some Cytokines Expression in ITP Primary Immune Thrombocytopenic

Recruiting
  • Primary Immune Thrombocytopenia
  • Plasma RNA isolation, qPCR analysis of micro RNA
  • +2 more
  • Sohag, Egypt
    Sohag University
May 7, 2022

Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • eltrombopag and romiplastim
  • (no location specified)
Nov 16, 2023

Immune Markers in Pediatric ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
  • (no location specified)
Oct 17, 2023

Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)

Completed
  • Idiopathic Thrombocytopenic Purpura
  • +2 more
  • Romiplostim
  • (no location specified)
Nov 10, 2022

Multiple Sclerosis Trial in Los Angeles (Blood draw for future biomarker analysis)

Completed
  • Multiple Sclerosis
  • Blood draw for future biomarker analysis
  • Los Angeles, California
    Investigational Site Number 8400001
Mar 15, 2022

Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)

Not yet recruiting
  • Immune Thrombocytopenia
  • peripheral blood and bone marrow withdrawal
  • (no location specified)
Jan 12, 2023

Pediatric Primary Immune Thrombocytopenia (ITP)

Recruiting
  • Primary Immune Thrombocytopenia
  • data collection
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • (no location specified)
Jan 12, 2023

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)

Enrolling by invitation
  • Lupus Erythematosus, Systemic
  • +3 more
  • rapid GCs taper
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Aug 16, 2022

Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)

Recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 17, 2023

Immune Thrombocytopenia Trial in Hong Kong (Eltrombopag)

Suspended
  • Immune Thrombocytopenia
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

Not yet recruiting
  • Immune Thrombocytopenia
  • Pregnancy Related
  • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
  • intravenous immunoglobulin
  • (no location specified)
Dec 1, 2022

ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Sep 27, 2022

Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (Immune Globulin Intravenous (Human), 10% Triple Virally Reduced

Completed
  • Immune Thrombocytopenic Purpura (ITP)
  • Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
  • Brno, Czechia
  • +10 more
Apr 29, 2021

Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (eltrombopag)

Completed
  • Immune Thrombocytopenic Purpura (ITP)
  • Nyack, New York
  • +31 more
Nov 3, 2022

Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)

Recruiting
  • Primary Immune Thrombocytopenia
  • Ianalumab
  • +2 more
  • Singapore, Singapore
    Novartis Investigative Site
Jan 23, 2023

Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)

Completed
  • Purpura, Thrombocytopenic, Idiopathic
  • BIVV009 6.5 grams
  • BIVV009 7.5 grams
  • Georgetown, District of Columbia
  • +4 more
Apr 22, 2022

Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Bruton Tyrosine Kinase
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 6, 2022

Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

Recruiting
  • Immune Thrombocytopenia
  • Suzhou, Jiangsu, China
    Jie Yin
Apr 19, 2022

Immune Thrombocytopenia Trial in Jena

Recruiting
  • Immune Thrombocytopenia
    • Jena, Germany
      University Hospital Jena
    Mar 29, 2022

    Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

    Recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Eltrombopag (Revolade®)
    • standard therapy (without eltrombopag): HD-DXM
    • Aarau, Switzerland
    • +5 more
    Sep 5, 2022

    Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • TPO-RAs
    • TPO-RAs combining anti-CD 20 monoclonal antibody
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Feb 7, 2023